41090211000001106: Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)
\UK product\Virtual medicinal product\Rivastigmine 13.3mg/24hours transdermal patches\Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)
\UK product\Virtual therapeutic moiety\Rivastigmine\Rivastigmine 13.3mg/24hours transdermal patches\Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)
\UK product\Trade family\Almuriva\Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing acetylcholinesterase inhibitor (product)\Product containing centrally acting acetylcholinesterase inhibitor\Product containing rivastigmine\Rivastigmine\Rivastigmine 13.3mg/24hours transdermal patches\Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase\Product containing rivastigmine\Rivastigmine\Rivastigmine 13.3mg/24hours transdermal patches\Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing carbamate\Product containing rivastigmine\Rivastigmine\Rivastigmine 13.3mg/24hours transdermal patches\Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)
\Medicinal product\Product containing autonomic agent\Product containing parasympathomimetic agent (product)\Product containing acetylcholinesterase inhibitor (product)\Product containing centrally acting acetylcholinesterase inhibitor\Product containing rivastigmine\Rivastigmine\Rivastigmine 13.3mg/24hours transdermal patches\Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)
\Medicinal product\Product containing autonomic agent\Product containing parasympathomimetic agent (product)\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase\Product containing rivastigmine\Rivastigmine\Rivastigmine 13.3mg/24hours transdermal patches\Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 23-Nov 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

2404481000001118 Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2404491000001116 Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)	Is a	Rivastigmine 13.3mg/24hours transdermal patches	true	Inferred relationship	Existential restriction modifier
Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)	Is a	Almuriva	true	Inferred relationship	Existential restriction modifier
Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)	Has specific active ingredient	Rivastigmine	true	Inferred relationship	Existential restriction modifier
Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)	Has dispensed dose form	Prolonged-release transdermal patch	true	Inferred relationship	Existential restriction modifier
Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd) 30 patch	Has AMP	True	Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2404481000001118	Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
2404491000001116	Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module